These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25045300)

  • 1. Resting energy expenditure is not associated with disease activity in women with rheumatoid arthritis: cross-sectional study.
    Choe JY; Park SH; Lee H; Kwon HH; Kim SK
    Korean J Intern Med; 2014 Jul; 29(4):516-24. PubMed ID: 25045300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study.
    Choe JY; Bae J; Lee H; Bae SC; Kim SK
    Rheumatol Int; 2013 Sep; 33(9):2373-9. PubMed ID: 23553517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CCP antibodies are not a marker of severity in established rheumatoid arthritis: a magnetic resonance imaging study.
    Porto LS; Tavares WC; Costa DA; Lanna CC; Kakehasi AM
    Rev Bras Reumatol Engl Ed; 2017; 57(1):15-22. PubMed ID: 28137398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.
    Tan YK; Li H; Allen JC; Thumboo J
    Int J Rheum Dis; 2020 Oct; 23(10):1337-1343. PubMed ID: 33460311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
    Kim SK; Park SH; Bae J; Son JT; Choe JY
    Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
    Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
    Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
    Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
    Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.
    Hamad MB; Marzouk S; Kaddour N; Masmoudi H; Fakhfakh F; Rebai A; Bahloul Z; Maalej A
    J Clin Lab Anal; 2014 Jan; 28(1):21-6. PubMed ID: 24375820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
    Lee SW; Kim SY; Chang SH
    BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism.
    Arshad A; Rashid R; Benjamin K
    Mod Rheumatol; 2007; 17(6):470-5. PubMed ID: 18084698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
    Heidari B; Firouzjahi A; Heidari P; Hajian K
    Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New resting energy expenditure prediction equations for patients with rheumatoid arthritis.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Koutedakis Y; Nevill AM; Douglas KM; Kita M; Kitas GD
    Rheumatology (Oxford); 2008 Apr; 47(4):500-6. PubMed ID: 18304942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Rheumatoid Arthritis, what is new?
    Gavrilă BI; Ciofu C; Stoica V
    J Med Life; 2016; 9(2):144-8. PubMed ID: 27453744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
    Dhaon P; Das SK; Srivastava R; Dhakad U
    Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
    Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
    Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.